IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q4 2020 Holdings

Filed 2021-02-17 | 12 holdings | $34.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$33.8M138,01799.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$56.9K364,2740.2%
United Therapeutics Corp(UTHR)COM91307C102$49.0K322,5370.1%
Taro Pharmaceutical IndusCOMM8737E108$40.6K553,6460.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$39.7K82,2000.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$36.2K858,8110.1%
Alkermes PLC(ALKS)COMG01767105$32.3K1,620,6750.1%
Mckesson Corp(MCK)COM58155Q103$29.0K166,9830.1%
Surgalign Holdings IncCOM86882C105$14.1K6,423,4080.0%
Invacare CorpCOM461203101$8.1K904,5470.0%
Anaptysbio Inc(ANAB)COM032724106$2.4K110,4480.0%
Nextcure IncCOM65343E108$33030,2920.0%